1098591-74-2

Upstream product

• 104044-86-2 [1-Amino-2-(4-chloro-phenyl)-ethyl]-phosphonic acid diethyl ester 
• 400653-36-3 1-{[(1,1-dimethylethyl)oxy]carbonyl}-1H-benzimidazole-5-carboxylic acid 

Relevant academic research and scientific papers

Neutrophil inhibitors to reduce inflammatory response

The invention provides novel compounds selected from the group consisting of: The compounds of the present invention are useful for the treatment and prevention of a variety of diseases and conditions associated with undesirable or abnormal inflammatory responses, such as ischemia-reperfusion injury. Accordingly, the invention further provides pharmaceutical compositions comprising these compounds. The invention still further provides methods of treatment or prevention for the above disorders using theses compounds or the compositions containing them.